Management of bronchopulmonary dysplasia
详细信息 查看全文
- 作者：Philippa Bowen ; Nicola C. Maxwell
- 关键词：bronchopulmonary dysplasia ; chronic lung disease of prematurity ; corticosteroids ; diuretics ; macrolides ; oxygen therapy
- 刊名：Paediatrics and Child Health
- 出版年：January, 2014
- 年：2014
- 卷：24
- 期：1
- 页码：27-31
- 全文大小：168 K
文摘
Bronchopulmonary dysplasia (BPD) is a common and important complication of prematurity and is associated with significant mortality, morbidity and healthcare resource utilization. Despite advances in both perinatal and neonatal care the incidence of the condition continues to rise. The management of BPD and its related problems remains a major challenge to neonatologists and paediatricians. There is unlikely to be a single intervention which will dramatically alter the management of BPD and thus multiple interventions have been proposed to prevent and treat the disease. Many of these interventions are still not evidence based and some of those that are have been shown to have unacceptable long-term effects. It is useful to conceptualize BPD in three stages, namely (i) prevention, (ii) treatment of evolving BPD and (iii) treatment of established BPD. In this review current and potential future management approaches to BPD and the relevant evidence for these are discussed within the framework of these three stages.